Back
Axsome Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
47
AXSM
Axsome Therapeutics
Last Price:
93.17
Seasonality Move:
12.35%
Buy
53
VRTX
Vertex Pharmaceuticals
Last Price:
468.10
Seasonality Move:
-1.23%
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
- The current Axsome Therapeutics [AXSM] share price is $93.13. The Score for AXSM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $467.99. The Score for VRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $93.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing slight buying pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $467.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.23 | Buy |
| Relative Strength Index (14 RSI): | 64.3 | Buy |
| Chaikin Money Flow: | 25836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (84.37 - 90.73) | Buy |
| Bollinger Bands (100): | (73.4 - 86.32) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.39 | Sell |
| Relative Strength Index (14 RSI): | 40.67 | Sell |
| Chaikin Money Flow: | 95532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (468.73 - 487.59) | Sell |
| Bollinger Bands (100): | (428.31 - 493.57) | Buy |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.91 | Buy |
| 20-day SMA: | 88.33 | Buy |
| 50-day SMA: | 85.54 | Buy |
| 200-day SMA: | 79.36 | Buy |
| 8-day EMA: | 91.43 | Buy |
| 20-day EMA: | 89.07 | Buy |
| 50-day EMA: | 85.58 | Buy |
| 200-day EMA: | 79.17 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 481.26 | Sell |
| 20-day SMA: | 478.84 | Sell |
| 50-day SMA: | 482.79 | Sell |
| 200-day SMA: | 434.24 | Buy |
| 8-day EMA: | 477.48 | Sell |
| 20-day EMA: | 480.1 | Sell |
| 50-day EMA: | 477.37 | Sell |
| 200-day EMA: | 437.27 | Buy |
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.99 per share, a decrease this year of $1.26 per share, and an increase next year of $3.97 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $1.22 per share, a decrease this year of $14.90 per share, and an increase next year of $18.27 per share.
Axsome Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||